Welcome to OrthoVentions, the leading accelerator fund for musculoskeletal innovation. In collaboration with the esteemed musculoskeletal surgeon group at the Hospital for Special Surgery (HSS), we're reshaping the journey of surgeon-led innovations into market-ready solutions.
OrthoVentions has partnered with the world-renowned Hospital for Special Surgery (HSS), the world's leading academic medical center specializing in musculoskeletal health. Renowned for its consistent No. 1 ranking in orthopedics by U.S. News & World Report for 11 consecutive years, HSS is a pioneer in orthopedic and rheumatologic care, maintaining top rankings for 29 years.
Through this partnership, OrthoVentions works with HS2 – HSS's orthopedic surgeon group, leveraging a pipeline of innovations for market adoption. We tailor projects for seamless integration into larger entities through strategic acquisitions.
Managing Director & Co-Founder
OrthoVentions
Managing Director & Co-Founder
OrthoVentions
Chief Executive Officer & President
Hospital for Special Surgery
Chief Financial Officer
Hospital for Special Surgery
Chief of Minimally Invasive Spine Surgery
Hospital for Special Surgery & HS2
Chief Operating Officer
Hospital for Special Surgery
Founder & Principal
Tri-State Biologics
Former President | Stryker
President & Founder | K2M
Retired Ernst & Young Executive
Discover our pipeline of cutting-edge innovations, each poised to enhance your platform and deliver solutions that set new industry standards.
Ready to take the next step with your innovative idea? Submit your invention disclosure today and start your journey towards transforming healthcare with OrthoVentions.